Highlights include small molecule cytokine antagonists, a versatile ELISA for PPI inhibitor screening, next-generation CETSA platform, and advances in 3D cell culture.
Read More
The latest volume demonstrates how artificial intelligence, automation, and portable technologies are reshaping drug discovery, diagnostics and therapeutic development.
Read More
SLAS, the Society of Laboratory Automation and Screening, has introduced the 12 companies selected for the Innovation AveNEW program at SLAS Europe 2026 Conference and Exhibition, taking place 19-21 May in Vienna, Austria.
Read More